Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 23172583)

1.

Predictors of coronary lesions complexity in patients with stable coronary artery disease.

Aksakal E, Tanboga IH, Kurt M, Kaya A, Topcu S, Kalkan K, Sevimli S.

Angiology. 2013 May;64(4):304-9. doi: 10.1177/0003319712464815. Epub 2012 Nov 20.

PMID:
23172583
2.

Impacts of estimated glomerular filtration rate on coronary atherosclerosis and plaque composition before and during statin therapy in patients with normal to mild renal dysfunction: subanalysis of the TRUTH study.

Nozue T, Yamamoto S, Tohyama S, Fukui K, Umezawa S, Onishi Y, Kunishima T, Hibi K, Terashima M, Michishita I; TRUTH INVESTIGATORS.

Nephrology (Carlton). 2012 Sep;17(7):628-35. doi: 10.1111/j.1440-1797.2012.01628.x.

PMID:
22708952
3.

Impact of cholesterol metabolism on coronary plaque vulnerability of target vessels: a combined analysis of virtual histology intravascular ultrasound and optical coherence tomography.

Nasu K, Terashima M, Habara M, Ko E, Ito T, Yokota D, Ishizuka S, Kurita T, Kimura M, Kinoshita Y, Asakura Y, Tsuchikane E, Katoh O, Suzuki T.

JACC Cardiovasc Interv. 2013 Jul;6(7):746-55. doi: 10.1016/j.jcin.2013.02.018. Epub 2013 Jun 14.

4.

Serum creatinine is independently associated with angiographic extent of coronary artery disease in patients with stable angina pectoris.

Korkmaz Ş, Demirkan B, Altay H, Refiker Ege M, Çaldır V, Yılmaz MB, Güray Y, Güray Ü, Şaşmaz H.

Anadolu Kardiyol Derg. 2011 Aug;11(5):407-13. doi: 10.5152/akd.2011.107. Epub 2011 Jun 7.

5.

[Association of microalbuminuria and fasting insulin levels with presence and severity of coronary artery disease in non-diabetic cases].

Ekicibaşi E, Kaderli AA, Kazazoğlu AR, Ozdemir B.

Anadolu Kardiyol Derg. 2008 Feb;8(1):16-21. Turkish.

6.

Serum pentraxin 3 levels are associated with the complexity and severity of coronary artery disease in patients with stable angina pectoris.

Karakas MF, Buyukkaya E, Kurt M, Motor S, Akcay AB, Buyukkaya S, Karakas E, Bilen P, Sen N.

J Investig Med. 2013 Feb;61(2):278-85. doi: 10.231/JIM.0b013e31827c2971.

PMID:
23237880
7.

The effects of dyslipidemia on left ventricular systolic function in patients with stable angina pectoris.

Wang TD, Lee CM, Wu CC, Lee TM, Chen WJ, Chen MF, Liau CS, Sung FC, Lee YT.

Atherosclerosis. 1999 Sep;146(1):117-24.

PMID:
10487494
8.

Characterization of the effect of serum bilirubin concentrations on coronary endothelial function via measurement of high-sensitivity C-reactive protein and high-density lipoprotein cholesterol.

Yoshino S, Hamasaki S, Ishida S, Kataoka T, Yoshikawa A, Oketani N, Saihara K, Ichiki H, Kuwahata S, Fujita S, Takumi T, Yoshimoto I, Nakazaki M, Tei C.

Heart Vessels. 2013 Mar;28(2):157-65. doi: 10.1007/s00380-011-0228-z. Epub 2012 Mar 29.

PMID:
22457095
9.

Relation of C-reactive protein levels to presence, extent, and severity of angiographic coronary artery disease.

Auer J, Rammer M, Berent R, Weber T, Lassnig E, Eber B.

Indian Heart J. 2002 May-Jun;54(3):284-8.

PMID:
12216925
10.

The relation of serum gamma-glutamyl transferase levels with coronary lesion complexity and long-term outcome in patients with stable coronary artery disease.

Aksakal E, Tanboga IH, Kurt M, Kaygın MA, Kaya A, Isik T, Ekinci M, Sevimli S, Acikel M.

Atherosclerosis. 2012 Apr;221(2):596-601. doi: 10.1016/j.atherosclerosis.2012.01.044. Epub 2012 Feb 3.

PMID:
22369933
12.

High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.

Alber HF, Wanitschek MM, de Waha S, Ladurner A, Suessenbacher A, Dörler J, Dichtl W, Frick M, Ulmer H, Pachinger O, Weidinger F.

Eur J Clin Invest. 2008 Jun;38(6):372-80. doi: 10.1111/j.1365-2362.2008.01954.x.

PMID:
18489399
13.

HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.

PMID:
22149320
14.

Determinants of coronary artery disease in liver transplant candidates.

Aydinalp A, Atar I, Bal U, Aktas A, Ertan C, Atar A, Yildirir A, Ozin B, Muderrisoglu H, Haberal M.

Exp Clin Transplant. 2010 Jun;8(2):142-5.

15.
16.

Plasma fibronectin level and its association with coronary artery disease and carotid intima-media thickness.

Orem C, Durmuş I, Kilinç K, Baykan M, Gökçe M, Orem A, Topbaş M.

Coron Artery Dis. 2003 May;14(3):219-24.

PMID:
12702925
17.

Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin.

Iwata A, Miura S, Tanaka T, Ike A, Sugihara M, Nishikawa H, Kawamura A, Saku K.

Coron Artery Dis. 2012 Aug;23(5):315-21. doi: 10.1097/MCA.0b013e328352ffec.

PMID:
22617341
18.

Elevated serum adipocyte fatty acid-binding protein concentrations are independently associated with renal dysfunction in patients with stable angina pectoris.

Iwamoto M, Miyoshi T, Doi M, Takeda K, Kajiya M, Nosaka K, Nakayama R, Hirohata S, Usui S, Kusachi S, Sakane K, Nakamura K, Ito H.

Cardiovasc Diabetol. 2012 Mar 21;11:26. doi: 10.1186/1475-2840-11-26.

19.

High ratio of triglycerides to HDL-cholesterol predicts extensive coronary disease.

da Luz PL, Favarato D, Faria-Neto JR Jr, Lemos P, Chagas AC.

Clinics (Sao Paulo). 2008 Aug;63(4):427-32.

20.

Incremental diagnostic value of circulating pentraxin in patients with intermediate risk of coronary artery disease.

Haybar H, Assareh A, Ghotbi Y, Torabizadeh M, Bozorgmanesh M.

Heart. 2013 May;99(9):640-8. doi: 10.1136/heartjnl-2012-303560. Epub 2013 Mar 6.

PMID:
23468517
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk